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Abstract. Background: One of the most important
resistance mechanisms in bacteria is the increased
expression of multidrug efflux pumps. To combat efflux-
related resistance, the development of new efflux pump
inhibitors is essential. Materials and Methods: Ten
phosphorus ylides were compared based on their MDR-
reverting activity in multidrug efflux pump system consisting
of the subunits acridine-resistance proteins A and B (AcrA
and AcrB) and the multidrug efflux pump outer membrane
factor TolC (TolC) of Escherichia coli K-12 AG100 strain
and its AcrAB-TolC-deleted strain. Efflux inhibition was
assessed by real-time fluorimetry and the inhibition of
quorum sensing (QS) was also investigated. The relative
gene expression of efflux QS genes was determined by real-
time reverse transcriptase quantitative polymerase chain
reaction. Results: The most potent derivative was
Ph3P=C(COC2F5)CHO and its effect was more pronounced
on the AcrAB-TolC-expressing E. coli strain, furthermore the
most active compounds, Ph3P=C(COCF3)OMe,
Ph3P=C(COC2F5)CHO and Ph3P=C(COCF3)COMe,
reduced the expression of efflux pump and QS genes.
Conclusion: Phosphorus ylides might be valuable EPI
compounds to reverse efflux related MDR in bacteria.
Multidrug resistance (MDR) is a serious problem for the
treatment of various diseases, such as bacterial and fungal
infections and cancer, due to reduction or deficit response of
microorganisms as well as cancer cells to applied
chemotherapeutic agents (1, 2).
One of the major mechanisms of MDR is the
overexpression of efflux pumps (EPs), which reduces the
accumulation of toxic agents. In bacteria the resistance
nodulation division (RND) transporters have a great impact on
MDR phenotype. The major cause for the MDR phenotype is
due to overexpression of efflux pumps that are part of the
RND family of transporters, for example the acridine-
resistance proteins A and B (AcrA and AcrB) and the
multidrug efflux pump outer membrane factor TolC (TolC)
AcrAB-TolC system (1). These efflux pumps have the ability
to recognize and extrude a large variety of unrelated
antibiotics from the periplasmic space of the cell envelope, or
from the cytoplasm. The energy required for the operation of
the efflux pump is provided by the proton motive force created
by the proton gradient resulting from electron transport (3).
The quorum-sensing system (QS) in bacteria is a
regulatory system that controls gene expression depending
on the density of the bacterial cell population. A
transcriptional regulator (LuxR homolog), signal synthase
(LuxI homolog) and autoinducer (acyl homoserine lactone)
are crucial for the QS in most Gram-negative bacteria. SdiA,
an E. coli LuxR homolog, has a great impact on the
colonization of E. coli (4, 5). SdiA is a homolog of QS
regulators that detects N-acylhomoserine lactone (AHL)
signals from other bacteria. SdiA represses the expression of
virulence factors by interacting with unknown stationary-
phase signals in E. coli O157:H7, and enhances multidrug
resistance by activating MDR efflux pumps in E. coli (6).
Organic compounds of phosphorus ylides (P-ylides) are a
fascinating class of compounds (7). The biological activity
of P-ylides related to their ATP-binding cassette subfamily
B member 1 (ABCB1)-modulating activity in mouse
lymphoma cells has already been described (8), however,
additional information is needed to describe their valuable
biological activities in other aspects. 
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In this article, we report the MDR-modulating activities
of P-ylides in bacteria related to the inhibition of efflux
activity and QS.
Materials and Methods
Compounds. The synthesis of P-ylides was described previously (8)
and the structures of the P-ylides (compounds 1-10) screened for
their MDR-modulating activities are shown in Table I. The
compounds were dissolved in dimethyl sulfoxide (DMSO) for the
experiments.
Acridine orange (AO), ethidium bromide (EB), and LB broth
were purchased from Sigma-Aldrich Chemie GmbH (Steinheim,
Germany). Modified LB agar (LB*) contained 5 g yeast extract, 
10 g trypton, 10 g NaCl, 1 g K2HPO4, 0.3 g MgSO4.7H2O and 36
mg FeNaEDTA in 1.0 l of distilled water. Mueller Hinton broth was
purchased from Scharlau Chemie S.A. (Barcelona, Spain).
Bacterial strains. Wild-type E. coli K-12 AG100 strain [argE3
thi-1 rpsL xyl mtl Δ(gal-uvrB) supE44] expressing the AcrAB-
TolC EP at its basal level and its AcrAB-TolC-deleted mutant
strain (E. coli K-12 AG100A). The strains were kindly provided
by Professor Dr. Hiroshi Nikaido (Department of Molecular and
Cell Biology and Chemistry, University of California, Berkeley,
CA, USA).
Strains used for QS tests: Chromobacterium violaceum 026
(CV026) as sensor strain; Sphingomonas spp. EZF 10-17
(Sphingomonadaceae) isolated from a grapevine crown gall tumor
(used as AHL producer), this strain induced pigment production by
CV026 and proved to be efficient for the study of QS interactions;
Enterobacter cloaceae 31298 (clinical wound isolate, used as AHL
producer).
Determination of minimum inhibitory concentrations. The minimum
inhibitory concentrations (MICs) of P-ylides were tested according
to Clinical and Laboratory Standard Institute guidelines (9).
Real-time accumulation assay by Roche LightCycler real-time
thermocycler. The effect of the studied compounds on the real-
time accumulation of EB was assessed by an automated EB
method (10), using a LightCycler real-time thermocycler
(LightCycler 1.5; Roche, Indianapolis, IN, USA). Briefly, an
aliquot of an overnight culture of the strain in LB medium was
transferred to fresh LB medium and incubated until it reached an
optical density (OD) of 0.6 at 600 nm. It was then washed with
phosphate-buffered saline (PBS; pH 7.4) and centrifuged at
13,000 × g for 3 min, the pellets re-suspended in PBS (pH 7.4)
and the OD adjusted to 0.6 at 600 nm. The compounds were
added individually at different concentrations (in double
concentrated form) in 5 μl volumes of their stock solutions to 45
μl of EB solution of 2 mg/l in PBS. Then, 10 μl of the EB
solution containing the compound were transferred into standard
glass capillary tubes of 20 μl maximum volume (Roche) and 10
μl of bacterial suspension (OD of 0.6 at 600 nm) was added to
the capillaries. The capillaries containing the samples were placed
into a carousel (Roche) and the fluorescence was monitored at the
FL-2 channel every minute on a real-time basis.
From the real-time data, the activity of the compound, namely
the relative fluorescence index (RFI) of the last time point (minute
30) of the EB accumulation assay was calculated according to the
formula:
where RFtreated is the relative fluorescence at the last time point of
the EB retention curve in the presence of an inhibitor, and
RFuntreated is the relative fluorescence at the last time point of the
EB retention curve of the untreated solvent control (DMSO).
Assay for QS inhibition. LB* was used for these experiments. The
sensor strain C. violaceum 026 (CV026) and the AHL producer
strains EZF 10-17 Sphingomonas spp. (Sphingomonadaceae) or E.
cloaceae 31298 were inoculated as parallel lines and incubated at
room temperature (20˚C) for 24-48 h. QS inhibition was monitored
by agar diffusion method. Filter paper discs (7.0 mm in diameter)
were impregnated with 10 μl of stock solutions of the compounds
in DMSO (10 mg/ml in DMSO). The discs were placed between the
parallel lines of sensor and AHL producer strains on the surface of
the nutrient agar. The plates were incubated at room temperature for
a further 24-48 h and the interactions between the strains and
compounds were evaluated for the reduction in size of the zone of
pigment production and the zone of growth inhibition of the affected
strains, in millimeters. AO was applied as positive control (11).
Expression analyses of genes by real-time reverse transcriptase
quantitative polymerase chain (RT-qPCR) reaction. Bacteria were
cultured in LB broth and were incubated overnight at 37˚C with
shaking. On the day of RNA isolation, the bacterial suspensions
(OD of 0.6 at 600 nm) were transferred to 10 ml tubes in 3 ml
aliquots and 50 μg/ml of compounds were added to the tubes
which were the incubated at 37˚C. At intervals of 4 and 18 h of
culture, the tubes were centrifuged at 12,000 × g for 2 min. Pellets
were suspended in 100 μl TE buffer containing 1 mg/ml lysozyme
by vigorous vortexing and were incubated at 37˚C for 10 min. The
total RNA was isolated in an RNase-free environment using
NucleoSpin RNA kit (Macherey Nagel, Germany) according to the
manufacturer’s instructions. Purified RNA was stored in RNase-
free water in nuclease-free collection tubes and was maintained at
−20˚C until quantification was performed. The concentration of
the extracted RNA templates was assessed by spectrophotometry
at 260 nm. 
Expression of the acrA, acrB, multiple antibiotic resistance protein
R (marR) and quorum-sensing transcriptional activator (sdiA) genes
was studied by reverse transcription of total RNA. The data obtained
for gene targets were normalized against the E. coli house-keeping
gene glyceraldehyde-3-phosphate-dehydrogenase (gapdh) measured in
the same sample. Real-time quantification of the RNA templates by
real-time one-step RT-qPCR was performed in a CFX96 Touch real-
time PCR detection system (Bio-Rad, Hercules, CA, USA) strictly
adhering to the manufacturer recommendations of the SensiFAST™
SYBR No-ROX One-Step Kit (Bioline GmbH, Luckenwalde,
Germany). Briefly, each well of 96-well microtiter plates contained,
in a final volume of 20 μl, 10 μl of the 2x SensiFAST™ SYBR No-
ROX One-Step Mix, 0.2 μl Reverse Transcriptase, 0.4 μl RiboSafe
RNase Inhibitor, 5.4 μl diethylpyrocarbonate-treated water, 500 nM of
each primer and approximately 20 ng of total RNA in RNAase-free
water. Thermal cycling was initiated with a denaturation step of 5 min
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at 95˚C, followed by 40 cycles each of 10 s at 95˚C, 30 s at 57˚C and
20 s at 72˚C. 
The forward and reverse primers used for assessment of the
activity of the transporter genes acrA, acrB, the regulator marR and
the QS regulator sdiA are shown in Table II.
Results
Compounds 1-10 did not have any antibacterial effect on the
AcrAB-TolC-expressing E. coli AG100 (MDR) strain nor its
AcrAB-TolC-deleted progeny E. coli AG100A (EP-deleted
strain) (MIC above 100 μg/ml), except for 6, which had a
mild, non-significant effect on the EP-deleted strain
(MIC=50 μg/ml).
The activity of the compounds was compared based on the
relative final fluorescence index (RFI) of the real-time
accumulation curves (Table III).
In the case of real-time EB accumulation by Light Cycler
thermocycler, the amount of EB accumulated by cells is
higher if the difference between RFtreated and RFuntreated is
greater, therefore, the degree of inhibition of the EP system
by the compound becomes greater. 
The majority of the P-ylides were found to inhibit the
AcrAB-TolC system of E. coli except Ph3P=C(COCF3)COPh
(3), Ph3P=C(COC2F5)COPh (7) and Ph3P=C(COC3F7)COPh
(8), which had little or no effect on the intracellular EB
accumulation in the E. coli AG100 and the AG100A strains.
Among the P-ylide series, Ph3P=C(COCF3)OMe (2),
Ph3P=C(COCF3)CHO (4) and Ph3P=C(COCF3)COMe (5)
exhibited strong AcrAB-TolC pump-inhibiting properties
compared to the AcrAB-TolC pump-deficient mutant strain.
The most potent derivative was 4 and its effect was more
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Table I. Structures of P-ylides (compounds 1-10).
Compound                                     R1                                     R2
1                                                 COCF3                                CN
2                                                 COCF3                               OMe
3                                                 COCF3                              COPh
4                                                 COCF3                               CHO
5                                                 COCF3                              COMe
6                                                 COCF3                              CO2Et
7                                                COC2F5                             COPh
8                                                COC3F7                             COPh
9                                                COCH3                                CN
10                                                   H                                     CN
Figure 1. Relative gene expression levels of the genes of the acridine
resistance protein A (acrA), acridine resistance protein B (acrB),
multiple antibiotic resistance protein R (marR) and quorum-sensing
transcriptional activator (sdiA) in the presence of compounds 2 (A), 4
(B), and 5 (C) after 4 and 18 h exposure in LB. The line denotes the
threshold value, which was set at a two-fold increase in transcripts. 
pronounced on the MDR E. coli strain compared to the
pump-deleted E. coli strain. This activity suggests that the
compound may interfere with the proton motive force
because AcrB utilizes proton motive force as energy for its
transport function.
The P-ylides were not able to inhibit the QS in the applied
systems compared to the positive control AO (data not shown).
Regarding the effect of P-ylides on the relative expression
of efflux pump and QS genes in E. coli AG100, the most
effective compounds 2, 4, and 5 were selected for gene-
expression studies. In the assay, the gene of the multidrug
efflux pump subunit AcrB, the gene of the periplasmic AcrA
subunit, the component of the E. coli mar locus (multiple
antibiotic resistance), and the gene of the LuxR homolog
SdiA were investigated. As shown in Figure 1A, compound
2 at 50 μg/ml up-regulated all the genes studied after 4 h of
exposure, however, after 18 h, the gene expression returned
to basal levels. Compound 4 also significantly up-regulated
the secondary RND transporter gene acrB (approximately 2-
fold increase) after 4 h and 18 h exposures as well.
Surprisingly, there was up-regulation of sdiA expression after
18 h compared to the expression level after 4 h implicating
the ability of compound 2 to influence the QS gene sdiA,
however, this increase was not significant (Figure 1B).
Compound 5 up-regulated the expression levels of acrA and
acrB after 4 h, although after 18 h, the up-regulation of these
genes was not significant (less than 2-fold increase) as
presented by Figure 1C.
Discussion
Some phenothiazines and hydantoins are known to be EPIs
against both bacteria and cancer cells (13). However, P-
ylides 3, 7 and 8 have been shown to have activity against
the EPs of cancer cells (8), but not to have activity against
the EP of bacteria. It is important to note that ABC
transporters are primary efflux pumps deriving their energy
from the hydrolysis of ATP, however, the AcrAB-TolC
system is a three-component proton motive force-dependent
multidrug efflux system. The most effective compounds in
the present bacterial system were compounds 2, 4, and 5,
which inhibited the AcrAB-TolC system and influenced the
expression of the genes acrA and acrB, which are
constituents of the AcrAB-TolC system. In addition, although
the compounds are not QS inhibitors, compound 4 did
increase the expression of sdiA after 18 h exposure.
It can be concluded that in the COCF3 series (compounds
1-6), the MDR-reverting activity in the MDR E. coli strain
was intensified in the following order: CHO (4) > OMe (2),
COMe (5) >> CO2Et (6), COPh (3), CN (1).
in vivo 30: 813-818 (2016)
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Table II. Forward and reverse primers used for assessment of the activity of the transporter genes acrA and acrB, the regulator marR and the
quorum-sensing regulator sdiA of Escherichia coli AG100.
Gene                                 Full name                                                                    Primer sequence (5’-3’)                                        Amplicon    Reference
                                                                                                                                                                                                             size (bp)
acrA                 Acridine-resistance protein A                  CTTAGCCCTAACAGGATGTGTTGAAATTACGCTTCAGGAT           189               (12)
acrB                 Acridine-resistance protein B                  CGTACACAGAAAGTGCTCAACGCTTCAACTTTGTTTTCTT          183               (12)
marR        Multiple antibiotic-resistance protein R          AGCGATCTGTTCAATGAAATTTCAGTTCAACCGGAGTAAT          170               (12)
sdiA         Quorum-sensing transcriptional activator     CTGATGGCTCTGATGCGTTTATCTGGTGGAAATTGACCGTATT       163          This study
gapdh    Glyceraldehyde-3-phospate dehydrogenase      ACTTACGAGCAGATCAAAGCAGTTTCACGAAGTTGTCGTT          170               (12)
Table III. Relative final fluorescence index (RFI) for the effect of P-ylides
(compounds 1-10) on Escherichia coli AG100 expresing acridine-resistance
proteins A and B and the multidrug efflux pump outer membrane factor
TolC, and the pump-deleted E. coli AG100A strain at 50 μg/ml.
Compound                                                      RFIa
                                                AG100                           AG100A
1                                                 0.36                                 0.46
2                                                 0.64                                 0.49
3                                                 0.04                                 0.12
4                                                 0.73                                 0.46
5                                                 0.42                                 0.27
6                                                 0.25                                 0.49
7                                                 0.02                                    0
8                                                   0                                    0.19
9                                                 0.29                                 0.32
10                                               0.42                                 0.44
aRFI was calculated according to the formula:
where RFtreated is the relative fluorescence at the last point (30 min) of
the ethidium bromide (EB) retention curve in the presence an P-ylide
and RFuntreated is the relative fluorescence at the last point (30 min) of
the EB retention curve of the untreated solvent control dimethyl
sulfoxide.
Thus, some structurally related trifluoroacetylated P-ylides
differ in their MDR-reversal activities between cancer cells
and bacterial strains, indicating that the compounds
differently act as inhibitors of primary (ABCB1) and
secondary (AcrB) efflux pumps because these pumps differ
in their energy source for driving the pump (ATP and PMF,
respectively). 
The present study demonstrated that trifluoroacetylated P-
ylides may be attractive lead EPIs for further development
as a MDR-reversing agents, however, their mode of action
should be elucidated by structure–activity relationship
studies. 
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